Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients
Authors:
- 18 July 2019
- book chapter
- Published by Springer Nature
- Vol. 179, 11-36
Abstract
Thrombosis is a major cause of morbidity and mortality in cancer patients. The pathogenesis of blood coagulation activation in oncological patients is complex and involves both clinical and biological factors. Abnormalities in one or more coagulation test are common in cancer patients, even without thrombotic manifestations, indicating an ongoing hypercoagulable condition. Moreover, venous thromboembolism (VTE) can be the first symptom of an occult malignancy in an otherwise healthy individual. The levels of laboratory markers of activation of blood coagulation parallel the development of malignancy, being the coagulant mechanisms important for both thrombogenesis and tumor progression. Besides general clinical risk factors for VTE, also disease-specific clinical factors, i.e., type and stage of the tumor, and anticancer therapies increase the thrombotic risk in these patients. Furthermore, biological factors, including the cancer cell-specific prothrombotic properties together with the host cell inflammatory response to the tumor, are relevant as well as unique players in the pathogenesis of the cancer-associated hypercoagulability. Cancer cells produce and release procoagulant and fibrinolytic proteins, inflammatory cytokines, and procoagulant microparticles. They also express adhesion molecules binding to the receptors of host vascular cells (i.e., endothelial cells, platelets, and leukocytes), thereby stimulating the prothrombotic properties of these normal cells, including the shed of cell-specific microparticles and neutrophil extracellular traps. Of interest, several genes responsible for the cellular neoplastic transformation drive the programs of hemostatic properties expressed by cancer tissues. A better understanding of such mechanisms will help the development of novel strategies to prevent and treat the Trousseau’s syndrome (i.e., cancer-associated thrombosis).Keywords
This publication has 143 references indexed in Scilit:
- Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosisProceedings of the National Academy of Sciences, 2012
- Extracellular DNA traps promote thrombosisProceedings of the National Academy of Sciences, 2010
- Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismThrombosis Research, 2010
- Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cellsBritish Journal of Cancer, 2009
- Epidemiology of cancer-related venous thromboembolismBest Practice & Research Clinical Haematology, 2009
- Tissue Factor Regulation by Epidermal Growth Factor Receptor and Epithelial-to-Mesenchymal Transitions: Effect on Tumor Initiation and AngiogenesisCancer Research, 2008
- Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patientsThrombosis Research, 2008
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007
- Microvesicle‐associated tissue factor and Trousseau's syndromeJournal of Thrombosis and Haemostasis, 2006
- Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancerInternational Journal of Cancer, 2004